Trial Profile
Safety and Immunogenicity of Concomitant Vaccination With IC51 and HARVIX 1440 in Healthy Subjects. A Single-blind Randomized, Controlled Phase 3 Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs IC 51 (Primary) ; Hepatitis A vaccine inactivated
- Indications Encephalitis virus infections; Hepatitis A
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Intercell
- 16 Jul 2009 Results published in the Vaccine journal.
- 02 Feb 2008 New trial record.